Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 45801-45850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06392724
A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.
EARLY_PHASE1Active, not recruiting
3 participants
Started: Jul 5, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03915327
Short-term Intravenous Iron Isomaltose Anhydride for IDA
NANot yet recruiting
1,600 participants
Started: Jul 5, 2024 · Completed: May 31, 2029
1 condition1 sponsor0 locations
NCT06668688
"Evaluation of the Naturalistic User Experience of the Website ich Bin Alles @Schule (i Am Everything @school)"
N/ARecruiting
100 participants
Started: Jul 5, 2024 · Completed: Jul 31, 2025
4 conditions2 sponsors1 location
NCT06675526
Detour: a Smartphone Game to Help Youth Quit Smoking
NARecruiting
604 participants
Started: Jul 5, 2024 · Completed: Aug 31, 2026
4 conditions3 sponsors1 location
NCT06621212
Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
PHASE2Recruiting
72 participants
Started: Jul 5, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT06375512
A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
PHASE1Active, not recruiting
150 participants
Started: Jul 5, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT06508216
A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
PHASE1/PHASE2Recruiting
50 participants
Started: Jul 5, 2024 · Completed: Dec 17, 2027
1 condition2 sponsors1 location
NCT06818838
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease
PHASE1/PHASE2Recruiting
18 participants
Started: Jul 5, 2024 · Completed: Jul 30, 2031
1 condition1 sponsor1 location
NCT06445933
Vitamin B6 and Depression in Pregnant and Peri-partum Women
NARecruiting
150 participants
Started: Jul 5, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06881745
Lifestyle and Nutrition Evaluation in Physically Active People and Athletes
N/ARecruiting
181 participants
Started: Jul 5, 2024 · Completed: Feb 28, 2026
4 conditions2 sponsors1 location
NCT06760234
Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
N/AActive, not recruiting
247 participants
Started: Jul 5, 2024 · Completed: Jul 1, 2029
1 condition3 sponsors1 location
NCT06285825
A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
PHASE2Recruiting
32 participants
Started: Jul 5, 2024 · Completed: Aug 22, 2028
1 condition2 sponsors1 location
NCT06808412
To Explore the Efficacy of Sintilimab Combined with Bevacizumab in Rectal Cancer
PHASE2Recruiting
118 participants
Started: Jul 5, 2024 · Completed: Jun 5, 2025
1 condition1 sponsor1 location
NCT06248619
A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
PHASE3Active, not recruiting
89 participants
Started: Jul 5, 2024 · Completed: Sep 29, 2026
1 condition1 sponsor39 locations
NCT06502704
Bile Acids and Microbiome in Early Colorectal Carcinogenesis
N/ARecruiting
60 participants
Started: Jul 5, 2024 · Completed: Jan 1, 2025
5 conditions2 sponsors1 location
NCT06590948
Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS
N/ARecruiting
50 participants
Started: Jul 5, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06591169
Lifestyle Changes in PCOS with OSA and NAFLD
NARecruiting
40 participants
Started: Jul 5, 2024 · Completed: Dec 15, 2024
3 conditions1 sponsor2 locations
NCT06992869
Mental Health Support for People Affected by Parkinson's
NAEnrolling by invitation
180 participants
Started: Jul 5, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06462105
Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
NANot yet recruiting
60 participants
Started: Jul 5, 2024 · Completed: Jun 30, 2027
1 condition6 sponsors0 locations
NCT06539455
Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs
N/AActive, not recruiting
127 participants
Started: Jul 5, 2024 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06582628
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
PHASE2Recruiting
78 participants
Started: Jul 5, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor12 locations
NCT06441721
Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient
N/ANot yet recruiting
60 participants
Started: Jul 5, 2024 · Completed: Sep 1, 2025
2 conditions1 sponsor0 locations
NCT06453798
Effect of Cervical Exercise Combined With Nerve Mobilization on Cervical Spondylotic Radiculopathy
NARecruiting
60 participants
Started: Jul 5, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06192394
Effect of Gum Chewing or Walking on Bowel Prep Quality and Patient Satisfaction Before Colonoscopy
NAActive, not recruiting
168 participants
Started: Jul 5, 2024 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT06497374
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
PHASE2Not yet recruiting
63 participants
Started: Jul 5, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor0 locations
NCT06484933
Risk Management in Primary Care
N/ANot yet recruiting
100 participants
Started: Jul 5, 2024 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06409026
Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension
PHASE4Recruiting
21 participants
Started: Jul 5, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06495333
Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD
N/ARecruiting
100 participants
Started: Jul 5, 2024 · Completed: Aug 20, 2025
1 condition1 sponsor1 location
NCT07143201
Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
PHASE2Recruiting
26 participants
Started: Jul 4, 2024 · Completed: Jul 31, 2027
2 conditions3 sponsors1 location
NCT06327646
Maternal Adherence to MMS in Nepal
NAActive, not recruiting
2,640 participants
Started: Jul 4, 2024 · Completed: Sep 30, 2025
1 condition3 sponsors119 locations
NCT06498479
ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
PHASE3Recruiting
460 participants
Started: Jul 4, 2024 · Completed: May 31, 2027
1 condition1 sponsor9 locations
NCT06809166
Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity
PHASE4Recruiting
40 participants
Started: Jul 4, 2024 · Completed: Jul 31, 2026
5 conditions6 sponsors3 locations
NCT06325020
Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
N/AActive, not recruiting
500 participants
Started: Jul 4, 2024 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT06298461
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
PHASE4Recruiting
418 participants
Started: Jul 4, 2024 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT06492447
Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer
N/ANot yet recruiting
50 participants
Started: Jul 4, 2024 · Completed: Mar 4, 2026
1 condition2 sponsors0 locations
NCT06542601
Combined Motor and Cognitive Training for Older Adults With Motoric Cognitive Risk Syndrome (CMC-training)
N/ARecruiting
204 participants
Started: Jul 4, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06497881
Upper Limb Movement Quality Following Stroke
N/ARecruiting
40 participants
Started: Jul 4, 2024 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT06841497
Safety and Efficacy Assessment of Unani Formulation 'Dolabi' in Management of Diabetes Mellitus Type II
NAActive, not recruiting
100 participants
Started: Jul 4, 2024 · Completed: Oct 3, 2025
2 conditions1 sponsor1 location
NCT06878508
DuoCor Ventricular Assist System Early Feasibility Study
NARecruiting
10 participants
Started: Jul 4, 2024 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06750211
Effect of MET With and Without MCTE in Mechanical Neck Pain
NARecruiting
50 participants
Started: Jul 4, 2024 · Completed: Jan 8, 2025
1 condition1 sponsor1 location
NCT06442748
Short Versus Long-term Levetiracetam in Brain Tumors
PHASE3Recruiting
604 participants
Started: Jul 4, 2024 · Completed: Jun 1, 2031
4 conditions1 sponsor1 location
NCT06528197
Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine
N/ARecruiting
1,000 participants
Started: Jul 4, 2024 · Completed: Dec 31, 2026
1 condition4 sponsors1 location
NCT06435208
Impact of Subgingival Instrumentation on Psychological Distress and Mental Health Status in Bruxers With Periodontitis
NARecruiting
45 participants
Started: Jul 4, 2024 · Completed: Feb 1, 2025
4 conditions1 sponsor1 location
NCT06451640
A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps
PHASE2Recruiting
60 participants
Started: Jul 4, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor19 locations
NCT06462469
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
PHASE4Recruiting
54 participants
Started: Jul 4, 2024 · Completed: Feb 17, 2028
1 condition1 sponsor17 locations
NCT06492655
To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
PHASE1Not yet recruiting
28 participants
Started: Jul 4, 2024 · Completed: Aug 8, 2024
1 condition1 sponsor0 locations
NCT06472934
Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement (B-TAVR)
NARecruiting
498 participants
Started: Jul 4, 2024 · Completed: May 31, 2028
1 condition1 sponsor4 locations
NCT06650605
Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PHASE1Recruiting
67 participants
Started: Jul 4, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations
NCT06476964
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
NARecruiting
200 participants
Started: Jul 4, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06573580
Primary Health Management for Chronic Obstructive Pulmonary Disease
NAActive, not recruiting
6,000 participants
Started: Jul 4, 2024 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location